Valiant Laboratories Limited (NSE:VALIANTLAB)
India
· Delayed Price · Currency is INR 116.99
+2.44 (2.13%)
Jul 4, 2025, 3:29 PM IST
Valiant Laboratories Revenue
In the fiscal year ending March 31, 2025, Valiant Laboratories had annual revenue of 1.33B INR, down -26.74%. Valiant Laboratories had revenue of 577.86M in the quarter ending March 31, 2025, with 88.92% growth.
Revenue
1.33B
Revenue Growth
-26.74%
P/S Ratio
3.81
Revenue / Employee
17.32M
Employees
77
Market Cap
5.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.33B | -486.75M | -26.74% |
| Mar 31, 2024 | 1.82B | -1.52B | -45.48% |
| Mar 31, 2023 | 3.34B | 215.43M | 6.90% |
| Mar 31, 2022 | 3.12B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition